Table 4 Change in SF-36 norm based Domain scores in non-responders among refractory HCV patients re-treated with pegylated interferon alpha 2b and ribavirin
SF-36 domain | Change in scores compared to baseline at | 48 wks to 24 wks (24 wk-48 wk) | ||
|---|---|---|---|---|
24 wks | 48 wks | 72 wks | ||
Physical Function | -1.20 | -1.37 | 1.36 | 0.62 |
Role-Physical | -4.34 | -5.49* | -0.11 | -1.16 |
Bodily Pain | -3.73* | -4.15* | 1.32 | -0.41 |
General Health | -1.18 | -3.03^ | -1.36 | -1.84 |
Vitality | -3.47** | -4.51* | 2.05 | -1.04 |
Social Functioning | -3.42 | -6.01* | -0.22 | -2.59 |
Role-Emotional | -1.20 | -4.42^^ | -0.63 | -2.42 |
Mental Health | -1.85 | -4.68* | 0.58 | -2.83 |
Physical Component Score | -3.34* | -2.83 | 1.08 | 0.51 |
Mental Component Score | -2.13 | -3.79* | 0.19 | -1.65 |